In 2007, an ambitions team of medical experts founded Medisure medical in the UAE with a goal of improving lives and delivering crucial heart treatment to sufferers across the region. After considerable success, Medisure was transformed again in 2016, when a group of industry leaders and powerful investors who brought more than 15 years of experience marketing medical equipment joined the company. With that extra backing and expertise, Medisure was in a position to expand its goals and expand its portfolio, offering more specialized treatment to more people, changing even more lives throughout the UAE.
Today, as part of Cardiovascular core therapies, we have brought new, innovate and effective solutions in a number of diverse fields, including Neuro Surgery, Spine and Orthopaedic Surgery, Neurology and General Surgery, delivering life-changing approaches to long term suffering. Our vision and drive is focused on improving the condition of chronic disease patients through cutting-edge medical technology, innovative therapies and constant improvement. Our team works tirelessly in partnership with partners throughout the industry, refining proven treatments and new approaches to provide effective treatment that transforms lives and delivers a brighter future for patients across the country.
Our extensive record in the UAE has established us as a leader in our field, bringing a host of new approaches to the country and our patients, including:
- Robotic Surgery
- Surgical Head Mounted Microscope
- Deep Brain Stimulation
- Bioresorbable Coronary stent
- Cardiac Ventricle Assist Device
- Transcatheter Aortic Valve Replacement
- Transcatheter Mitral Valve Repair
- ECG Mobile Cardiac Telemetry
- Medical 3D Printing
Our journey does not end here though, our commitment to identify, evaluate, refine and introduce new treatments to the UAE for the first time in order to ease suffering and change lives remains as strong as ever. We will continue to work with our partners and healthcare providers to deliver effective treatment.
CEO Message
"To deliver innovative therapeutic and diagnostic solutions that protect human and cure patients"
As medical technology advances rapidly, established ideas of treatment are constantly being challenged, and we are right at the forefront of that, leading the adoption of new thinking and innovation. Through effective relationships with industry partners, healthcare providers and physicians across the UAE, we identify, refine and deliver new treatments, new technological approaches, and new ideas to ease the suffering of patients with chronic disease. Our goal is to transform lives through medical innovation, today and into the future.
- Building a real partnership with healthcare providers and phy sicians, to introduce new solutions for patients.
- Continuous development to our team that will satisfy our cli ents and patients.
- Helping healthcare providers to adopt new solutions by con ducting workshop and required trainings.
- To be ethical, responsible and knowledgeable.
- To put our customers & patients first.
- To work with integrity and honesty.
In the year 2000 we entered the interventional cardiology market and immediately became the first cardiology company to develop and patent their own proprietary limus agent, Biolimus A9™ (BA9™), a highly lipophilic1 anti-restenotic drug designed for cardiovascular stent technologies. We were also the first stent company to develop and launch a biodegradable polymer stent with only the abluminal side coated with polymer and drug to reduce systemic exposure2.
We’ve been committed to this concept of saving lives since our founding in 2001 by a group of Swiss doctors and engineers. Since then we’ve developed industry leading balloons such as the 2008 launch of the unprecedented ACROSS CTOTM which was the smallest ever entry and crossing profile balloon. We’ve since added to the ACROSS CTOTM line in order to offer a versatile solution for every problem.
Our lauded specialty balloons were the result of listening to doctors’ concerns and finding a solution. Both variations of the GRIPTM balloon were in response to worries about restenosis and heavily calcified lesions while the GENIETM was a solution to the issue of drug delivery.
In 2017 we once again proved our commitment to doctors and patients when we introduced the M-CATHTM. This micro-catheter incorporated a unique dual shaft and was designed to combine powerful push and torque in order to assist doctors who were frustrated with their current micro-catheters’ inability to penetrate many CTOs. The same year we also expanded into extrusion production to ensure that every aspect of our balloons are of the highest quality.
QXMédical was founded in 2007 in Montreal, Canada on the principle of providing uncompromised value and quality in underserved high-growth segments of the medical device market. Today, the company is known for its innovative solutions for complex, minimally invasive procedures. Working closely with healthcare professionals and strategic partners, we apply our expert insight and know-how to produce unique products that make a difference in the lives of others.
In 2010, QXMédical established its Technology and Manufacturing Center in Roseville, Minnesota. Our new state-of-the-art facility is located squarely in the medical device hub of North America, and has allowed QXMédical to respond to increased demands from our customers and partners.
Asahi Intecc develops, produces and sells various medical devices required for catheter treatment. Treatment areas where these devices are used is not limited to cardiovascular system areas but also extends to areas of the peripheral vascular system, abdominal vascular system, cerebrovascular system and other areas. With ASAHI outstanding development capabilities and production technologies in the medical device field, they hold a high share not just in the Japanese market but also globally.
CNSystems’ core technologies are made for painless and reliable cardiovascular diagnosis, monitoring and therapy control in order to improve patient care and medical outcome. The company has achieved technological leadership in developing a noninvasive, easy-to-use and accurate diagnosis and patient monitoring systems for better and easier insights into the cardiovascular system and its control mechanism located in the brain.
A healthy heart is essential to good health. That's why at Abbott throws hearts into advancing treatments for people with cardiovascular disease. Abbott breakthrough medical technologies — many of which are minimally invasive — help restore people's health so they can get back to living their best lives, faster. Abbott focuses on innovative technologies that can improve the way doctors treat people with vascular diseases, heart arrhythmias (irregular heartbeats) and diseases of the heart’s valves.
In the year 2000 we entered the interventional cardiology market and immediately became the first cardiology company to develop and patent their own proprietary limus agent, Biolimus A9™ (BA9™), a highly lipophilic1 anti-restenotic drug designed for cardiovascular stent technologies. We were also the first stent company to develop and launch a biodegradable polymer stent with only the abluminal side coated with polymer and drug to reduce systemic exposure2.
Istem Medical is an establishment that takes place in the sales and marketing area of the medical sector since 1995. Today Istem Medikal has become the leader of the sector which has also started to export aiming to get first place in the international arena.
Istem Medicals vision is to accelerate the development of the health sector doing the best that possible.ISTEM MEDICAL that has EN ISO 9001:2015 and EN ISO: 13485:2016 quality certificates aims to be the pioneer in the sector.
Peters Surgical is a French company which develops, manufactures and sells medical devices for the surgeon. Péters Surgical is acting on the market of sterilized single use medical devices for operating room. It is specialized in sutures, devices for temporary and permanent vascular occlusion, wall reinforcement, surgical glue, single use instruments for laparoscopic surgery, drains, etc. Peters Surgical company is the unique French firm manufacturing and selling surgical sutures and is the European leader for haemostatic clips.
LSI SOLUTIONS was founded in 1986 by Jude S. Sauer, M.D., with a mission to lead the world in medical product innovation and passion to focus on patient outcomes. What once started with a focus on laser tissue welding has evolved into a world-renowned company dedicated to advancing minimally invasive therapeutics through research, development, manufacturing, and marketing of proprietary products.
Founded in Sweden in 2012, IRRAS is a commercial medical device company, focused on designing, developing, and commercializing innovative solutions that transform fluid management after surgical procedures where drainage is required
Copyright © 2023.
Medisure Medical. All Rights Reserved